- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 38.4M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.92M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.89M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $41.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $45.36M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $40.03M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $36.04M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $63.55M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $178.34M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $177.78M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $292.84M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $294.09M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 38.21M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $185K |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $956K |
| Capex | Q1 2025 · Mar 31, 2024 | $1.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$16.36M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $310.38M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $292.12M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.57 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $28.22M |
| Net Income | Q1 2025 · Mar 31, 2024 | $21.88M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.77M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $24.85M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $44.46M |
| Revenue | Q1 2025 · Mar 31, 2024 | $69.31M |